SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-23-017754
Filing Date
2023-11-06
Accepted
2023-11-06 16:01:44
Documents
63
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q vygr-20230930x10q.htm   iXBRL 10-Q 1793426
2 EX-31.1 vygr-20230930xex31d1.htm EX-31.1 13696
3 EX-31.2 vygr-20230930xex31d2.htm EX-31.2 13787
4 EX-32.1 vygr-20230930xex32d1.htm EX-32.1 10729
5 GRAPHIC vygr-20230930x10q006.jpg GRAPHIC 101018
  Complete submission text file 0001558370-23-017754.txt   7521035

Data Files

Seq Description Document Type Size
6 EX-101.SCH vygr-20230930.xsd EX-101.SCH 51033
7 EX-101.CAL vygr-20230930_cal.xml EX-101.CAL 48108
8 EX-101.DEF vygr-20230930_def.xml EX-101.DEF 214020
9 EX-101.LAB vygr-20230930_lab.xml EX-101.LAB 407396
10 EX-101.PRE vygr-20230930_pre.xml EX-101.PRE 336168
57 EXTRACTED XBRL INSTANCE DOCUMENT vygr-20230930x10q_htm.xml XML 1349753
Mailing Address 75 HAYDEN AVENUE LEXINGTON MA 02421
Business Address 75 HAYDEN AVENUE LEXINGTON MA 02421 857-259-5340
Voyager Therapeutics, Inc. (Filer) CIK: 0001640266 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37625 | Film No.: 231379892
SIC: 2836 Biological Products, (No Diagnostic Substances)